
Gilead’s dominance of the hepatitis C market is under severe threat after a federal jury ruled in favour of MSD …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

